We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
SEACOR Marine Holdings
SMHI
$216M
| $143K | ﹤0.01% |
10,592
-31,505
| -75% | -$410K |
|
|
MDV
2327
Modiv Industrial
MDV
$182M
| $143K | ﹤0.01% |
+10,097
| New | +$153K |
|
|
WEL.WS
2328
CALL
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
| $142K | ﹤0.01% |
12,269
| – | – |
|
2329
Cerence
CRNC
$382M
| $142K | ﹤0.01% |
50,100
-48,295
| -49% | -$344K |
|
2330
RLX Technology
RLX
$2.48B
| $142K | ﹤0.01% |
77,000
-226,560
| -75% | -$429K |
|
2331
Sera Prognostics
SERA
$80.3M
| $142K | ﹤0.01% |
23,922
-16,292
| -41% | -$146K |
|
|
EH
2332
EHang Holdings
EH
$372M
| $142K | ﹤0.01% |
10,420
-16,730
| -62% | -$283K |
|
|
ADAP
2333
DELISTED
Adaptimmune Therapeutics
ADAP
| $141K | ﹤0.01% |
144,880
-109,133
| -43% | -$120K |
|
2334
CALL
Qualcomm
QCOM
$176B
| $139K | ﹤0.01% |
+700
| New | +$132K |
|
2335
Vanda Pharmaceuticals
VNDA
$312M
| $138K | ﹤0.01% |
24,504
-42,141
| -63% | -$218K |
|
2336
Latham Group
SWIM
$646M
| $138K | ﹤0.01% |
45,500
| – | – |
|
|
CMRX
2337
DELISTED
Chimerix, Inc.
CMRX
| $137K | ﹤0.01% |
+156,076
| New | +$148K |
|
|
NEXN
2338
Nexxen International
NEXN
$547M
| $136K | ﹤0.01% |
+24,207
| New | +$141K |
|
2339
Corvus Pharmaceuticals
CRVS
$1.1B
| $136K | ﹤0.01% |
+74,559
| New | +$139K |
|
2340
Sunrun
RUN
$2.37B
| $135K | ﹤0.01% |
11,405
-1,542,040
| -99% | -$18.9M |
|
2341
Viavi Solutions
VIAV
$9.75B
| $135K | ﹤0.01% |
19,600
-1,814,859
| -99% | -$14.1M |
|
|
ARC
2342
DELISTED
ARC Document Solutions, Inc.
ARC
| $134K | ﹤0.01% |
50,799
-31,444
| -38% | -$84.4K |
|
2343
Clarivate
CLVT
$1.3B
| $132K | ﹤0.01% |
+23,219
| New | +$148K |
|
2344
InfuSystem Holdings
INFU
$184M
| $131K | ﹤0.01% |
+19,247
| New | +$141K |
|
|
SWI
2345
DELISTED
SolarWinds Corporation Common Stock
SWI
| $129K | ﹤0.01% |
+10,700
| New | +$124K |
|
2346
Aegon
AEG
$13.5B
| $129K | ﹤0.01% |
+21,001
| New | +$133K |
|
2347
Personalis
PSNL
$1.26B
| $129K | ﹤0.01% |
109,852
-101,050
| -48% | -$139K |
|
2348
Marqeta
MQ
$1.8B
| $128K | ﹤0.01% |
+5,850
| New | +$129K |
|
|
MNTX
2349
DELISTED
Manitex International, Inc.
MNTX
| $128K | ﹤0.01% |
+28,944
| New | +$168K |
|
2350
Gyre Therapeutics
GYRE
$662M
| $128K | ﹤0.01% |
10,720
-14,824
| -58% | -$203K |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.